| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Inc / Ma (VRTX) has 13 insiders with recent SEC Form 4 filings, including 4 buys and 8 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $57.38M | - | |
| COO | 63.4K | $27.24M | - | |
| VP | 51.1K | $21.96M | - | |
| VP | 42.3K | $18.18M | - | |
| Other | 24.0K | $10.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | Kewalramani Reshma55 | CEO &President | Buy | 10,000 | $389.58 | $3,895,767.70 | +4.6% | +9.3% | - | |
| Aug 6, 2025 | Sachs Bruce I51 | Director | Buy | 5,000 | $389.68 | $1,948,415.68 | +6.1% | +9.3% | - | |
| May 15, 2025 | Altshuler David48 | EVP, Chief Scientific Officer | Sell | 52 | $424.69 | $22,083.88 | -0.2% | -8.9% | - | |
| May 2, 2025 | Bhatia Sangeeta N.48 | Director | Sell | 400 | $505.86 | $202,344.00 | -7.6% | -8.8% | -15.4% | |
| Mar 13, 2025 | Altshuler David48 | EVP, Chief Scientific Officer | Sell | 3,231 | $510.00 | $1,647,810.00 | -12.2% | -10.0% | -6.7% | |
| Mar 10, 2025 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 3,242 | $499.99 | $1,620,967.58 | -6.0% | -10.8% | -0.2% | |
| Mar 10, 2025 | Wagner Charles F Jr50 | EVP &Chief Financial Officer | Sell | 3,298 | $500.00 | $1,649,000.00 | -6.0% | -10.8% | -0.2% | |
| Mar 10, 2025 | Altshuler David48 | EVP, Chief Scientific Officer | Sell | 3,231 | $500.00 | $1,615,500.00 | -10.9% | -10.8% | -0.2% | |
| Mar 4, 2025 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 4,058 | $485.49 | $1,970,118.42 | -6.9% | -8.4% | -1.7% | |
| Mar 3, 2025 | Altshuler David48 | EVP, Chief Scientific Officer | Sell | 3,231 | $490.00 | $1,583,190.00 | -9.8% | -7.8% | -1.9% |